Valoraciõn clínica, psicológica y de laboratorio a niños con hiperfenilalaninemia benigna al nacimiento

Revista Cubana de Pediatria

Volumn 74, Issue 4, 2002, Pages

  Gutiérrez García, Enna ^a   Barrios García, Bárbara ^a   Taboada, Lugo Noel ^b  

^a Centro Nacional de Genetica Medica   (Cuba)

^b Departamento Provincial de Genética   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 8344262933     PISSN: 00347531     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Berry H. Levy A, Penrose A. Diagnosis of phenylalanine hydroxilase deficiency. Am J Dis Child 1992; 136:111-4.
2. Centerwal WR. Phenylketonuria (Foiling disease): the story of its discovery. J Hist Med 1961;16:292.
3. Jervis GA. Studies on phenylpiruvic oligophrenia: the position of the metabolic error: J Biol Chem 1947; 169:651-6.
4. Scriver CR, Beaudet AL, Sly WS, Valle C. The metabolic and molecular basics of inherited disease. 7th ed. New York: Mac Graw-Hill, 1995:1015-75.
5. Abadie V, Jaruzelska J, Lyonnet S, Munnich A, Rey J. Illegitimate transcription of the phenylalanine hydroxilase gene in lymphocytes for identification of mutations in phenylketonuria. Hum Molec Genet 1993;2:31-4.
6. Hani S, Mac Dermott S, Ualtorta M. A Bayesian model for prediction of mental retardation in newborns. Res Dev Disabil 1997;18:303-18.
7. Yearning M, Murphy CC, Cordero J, Deocoufle P, Hollo well JG. Reported biomedical causes and associated medical conditions for mental retardation among 10 years-old children in metropolitan Atlanta 1985-1987. Dev Med Child Neurol 1997;39:142-9.
8. Wechsler D. Escala de inteligencia para el nivel escolar. Mexico DF. El Manual Moderno; 1997:204-14.
9. Garcia M. El WISC: su utilidad diagnostica en nifios con dificultades para aprender. Bol Psicol 1987;10:123-41.
10. Mac Caman MW and Robins E. Fluorimetric method for the determination of phenylalanine in serum. J Lab Clin Med 1962;59:885-90.
11. Addy D. Cognitive funcion in children with epilepsy. Dev Med Child Neurol 1997;24:294-04.
12. Behrman R, Kliegman R, Nelson W, Vauhan C. Dermatitis atópica. 2. ed. New York: Mac Graw-Hill;1992:721-4.
13. Schaefen T, Burgard P, Batzler V, Rupp A, Gilli G, Schmith H, et al. Growth and skeletal maturation in children with phenylketonuria. Acta Paediatr 1994;83:534-41.
14. Weglage J, Ullrich K, Pietsch M. Intellectual, neurologic and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia: German collaborative study on PKU. Pediatr Res 1997;42:378-84.
15. Berdesco A, Esquivel M, Gutierrez J, Jimenez J, Posada E. Trastornos del desarrollo. 3th ed. La Habana: Ed. Pueblo y Education, 1996;1:97-124.
16. Weglaje J, Ulrich K, Pietsch M, Funder B, Zass R, Koch HG. Untreated non-phenylketonuric hyperphenylalaninemia: intellectual and neurological outcome. Eur J Pediatr 1996;55:526-8.